Goat IgG anti-Ferret IgA-unconj., MinX none

Artikelnummer: DNA-SEC-183623
Artikelname: Goat IgG anti-Ferret IgA-unconj., MinX none
Artikelnummer: DNA-SEC-183623
Hersteller Artikelnummer: SEC-183623
Alternativnummer: DNA-SEC-183623
Hersteller: dianova
Wirt: Goat
Kategorie: Antikörper
Applikation: ELISA,IHC,WB
Spezies Reaktivität: Ferret
Immunogen: Ferret IgA alpha heavy chain
Konjugation: Unconjugated
Alternative Synonym: goat anti-Ferret IgA (alpha chain) Antibody
Format: IgG
Spezifität: IgA
Minimale Kreuzreaktivität (MinX): no cross-adsorbtion
Anti-Ferret IgA Antibody generated in goat detects immunoglobulin A from ferret. Immunoglobulin A (IgA) is an antibody that plays a critical role in mucosal immunity. IgA has two subclasses (IgA1 and IgA2) and can exist in a dimeric form called secretory
Klonalität: Polyclonal
Konzentration: 1.0 mg/mL
Isotyp: Ig
Puffer: 0.125 M Sodium Borate, 0.075 M Sodium Chloride, 0.005 M EDTA, pH 8.0
Reinheit: This product was prepared from monospecific antiserum by immunoaffinity chromatography using Ferret IgA coupled to agarose beads followed by solid phase adsorption(s) to remove any unwanted reactivities.   Assay by immunoelectrophoresis resulted in a single precipitin arc against anti-Goat Serum, Ferret IgA and Ferret Serum.  No reaction was observed against Ferret IgG or Ferret IgM.   Specificity was confirmed by ELISA at less than 1% cross reactivity against other Ferret heavy or light chain isotypes.
Formulierung: Liquid (sterile filtered)
Formel: 125 mM Sodium Borate,75 mM NaCl,5 mM EDTA,pH 8,0,sterile filtered,0,01% NaN3
Target-Kategorie: Ferret
Antibody Type: Secondary Antibody
Application Verdünnung: ELISA Dilution: 1:20,000 - 1:100,000, Immunohistochemistry Dilution: 1:1,000 - 1:5,000, Western Blot Dilution: 1:2,000 - 1:10,000
Anwendungsbeschreibung: This product is designed for immunofluorescence microscopy, fluorescence based plate assays (FLISA) and fluorescent western blotting. This product is also suitable for multiplex analysis, including multicolor imaging, utilizing various commercial platforms.